- Home
- CDNA vs OMI Comparison
CDNA vs OMI Comparison
Compare CDNA & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- OMI
- Stock Information
- Founded
- CDNA 1998
- OMI 1882
- Country
- CDNA United States
- OMI United States
- Employees
- CDNA N/A
- OMI N/A
- Industry
- CDNA Medical Specialities
- OMI Medical Specialities
- Sector
- CDNA Health Care
- OMI Health Care
- Exchange
- CDNA Nasdaq
- OMI Nasdaq
- Market Cap
- CDNA 944.1M
- OMI 909.7M
- IPO Year
- CDNA 2014
- OMI N/A
- Fundamental
- Price
- CDNA $22.79
- OMI $12.14
- Analyst Decision
- CDNA Buy
- OMI Buy
- Analyst Count
- CDNA 8
- OMI 6
- Target Price
- CDNA $27.17
- OMI $19.58
- AVG Volume (30 Days)
- CDNA 816.5K
- OMI 818.3K
- Earning Date
- CDNA 11-04-2024
- OMI 11-04-2024
- Dividend Yield
- CDNA N/A
- OMI N/A
- EPS Growth
- CDNA N/A
- OMI N/A
- EPS
- CDNA N/A
- OMI N/A
- Revenue
- CDNA $312,775,000.00
- OMI $10,660,960,000.00
- Revenue This Year
- CDNA $19.60
- OMI $4.87
- Revenue Next Year
- CDNA $10.26
- OMI $4.01
- P/E Ratio
- CDNA N/A
- OMI N/A
- Revenue Growth
- CDNA 5.26
- OMI 4.22
- 52 Week Low
- CDNA $7.42
- OMI $11.42
- 52 Week High
- CDNA $34.84
- OMI $28.35
- Technical
- Relative Strength Index (RSI)
- CDNA 42.58
- OMI 42.26
- Support Level
- CDNA $21.16
- OMI $11.75
- Resistance Level
- CDNA $24.42
- OMI $12.58
- Average True Range (ATR)
- CDNA 1.30
- OMI 0.60
- MACD
- CDNA 0.16
- OMI 0.00
- Stochastic Oscillator
- CDNA 43.83
- OMI 31.03
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.